- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- In-licensing
- View
Late stage products in CNS, immunology, infectious disease and dermatology areas
Full description
Astellas Pharma Taiwan, Inc, is committed to attentive partnering for commercial success by in-licensing in key indication areas for the Taiwanese market: -Urology disease - any late stage or currently marketed products. - Central nervous system: any late stage or currently marketed products. -Immunology: any late stage or currently marketed products. -Infectious disease: any late stage or currently marketed products. -Dermatology: any late stage or currently marketed products.
Development status
Type of business relationship sought
Licensing late stage or marketed prescription products for the Taiwanese market. Areas of interest include:
- Urology
- Central nervous system
- Immunology
- Infectious disease
- Dermatology
- Other niche markets.
Licensing contact
Project Manager
Marketing Dept
Company details
Astellas Pharma Taiwan Inc, is the leading Japanese Pharmaceutical Co. with a successful record. We wish to in-license branded ethical drugs for the Taiwan market.
Related reports
Related items
Related categories
- Industry sector
- Pharmaceutical
- Therapeutic target
- Central Nervous System
- Dermatological
- Gastrointestinal
- Immune related disorders
- Infectious diseases
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us